Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Web – sheet or filament bases; compositions of bandages; or...
Reexamination Certificate
1995-08-31
2001-03-27
Page, Thorman K. (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Web, sheet or filament bases; compositions of bandages; or...
C424S449000, C424S409000, C424S401000, C424S405000
Reexamination Certificate
active
06207181
ABSTRACT:
FIELD OF THE INVENTION
The invention relates to a reservoir with a delivery surface for the controlled delivery of active substances decreasing over the time of use to solid, liquid or gaseous acceptors, an apparatus for the controlled delivery of active substances decreasing over the time of use, its manufacture and the use thereof. More specifically, the present invention relates to transdermal therapeutic systems.
BACKGROUND OF THE INVENTION
The term active substances in the present context is understood to mean substances having a desired action, of either an optical, physical or chemical/biological nature, in a field of technology, medicine or biology, including pest control.
The delivery of active substances therefrom to a specific acceptor medium can take place in two ways with respect to the time function.
On the one hand the total desired active substance quantity can be supplied in a single portion and on the other hand the desired total quantity can be supplied discontinuously or continuously, subdivided into partial quantities of varying magnitude, over a given period of time to the acceptor medium. The present invention deals with the latter case.
The present invention relates to the delivery of active substance from a reservoir to a specific acceptor medium. Apart from the controllability of the active substance quantity delivered in time and in the time unit by the reservoir, it must also be possible here to control the active substance delivery characteristics. This requirement is in many cases unavoidable and e.g. in the case of transdermal, therapeutic systems plays an important part. These are active substance-containing apparatuses or administration forms, which deliver to the skin over a fixed time period and in a continuous manner one or more active substances with a predetermined rate. Considerable efforts have been made to realize these systems.
The aim of obtaining an approximately constant active substance delivery over a desired period of time has been achieved. Solution proposals exist for other active substance delivery characteristics which have not, however, been fully satisfied. Thus, use must be made of the composition of the reservoir matrix in connection with a controlled decrease in the active substance delivery over the administration period (in the case of medicaments this decrease is e.g. sought in the case of cortisone-containing products, as well as in nitroglycerin administration, but may also be necessary for adapting to the biorhythm of the organism under treatment). However, this only offers a limited scope, because it is also necessary to fulfil the basic requirement of the diffusability of the active substance in the matrix. The concentration and/or concentration distribution of the active substance in the matrix also offer possibilities of control in the desired sense, but can only be used in special cases.
U.S. Pat. No.4,564,364 proposes subdividing the active substance reservoir into volume areas, in which the active substance concentration is partly above and partly below the saturation concentration. Through a planned geometrical design of the volume areas, it is possible to influence the active substance delivery characteristics. Quite apart from the fact that the production of such systems is complicated and costly, it does not disclose the present technical teaching of solving the problem of a planned, controlled decrease in the active substance delivery over the administration or application time of the system.
Another way for controlling the active substance delivery from matrix reservoirs is given in German Patent 33 15 272. In this case the reservoir comprises at least two layers parallel to the delivery surface, which contain concentrations above the saturation concentration, the concentration increasing with increasing distance of the layer from the delivery surface. This admittedly makes it possible to keep the delivery rate at a given level for this desired time, but here again it is not possible to achieve a planned control of the decrease in the active substance delivery rate. EP-A-0 227 252 describes an active substance delivery characteristic particularly in connection with transdermal therapeutic systems, in which with the aid of an enhancer, it is possible to set a high delivery rate over a first part of the administration period, with a much lower delivery rate over a second part of said period. The construction and composition of the reservoir are very complicated and must be determined for each individual case on the basis of time-consuming preliminary tests. In addition, this system is limited to a two-stage active substance delivery characteristic.
SUMMARY OF THE INVENTION
The problem of the present invention is to permit a widely usable, clearly defined control decrease in the active substance delivery over a desired or necessary time.
Surprisingly the solution of this problem is found in that at least at one point the reservoir is provided a cross-sectional surface of that point of the reservoir which is smaller than the delivery surface and which is parallel thereto.
Advantageous further developments of the invention can be gathered from the dependent claims.
The delivery quantity of a substance over a period of time from a reservoir with a delivery surface is directly proportional to the size of the latter. The reservoir can be made from pure active substance or a reservoir material kept unchanged over the period of use and in which active substance is distributed. In the former case the delivery of the active substance leads to a wearing away of the reservoir, so that new delivery surfaces are constantly formed. If the cross-section of the reservoir parallel to the delivery surface is now reduced at at least one point, a size-reduced delivery surface is formed there, so that the active substance delivery is decreased.
In the latter case of a reservoir material with the active substance distributed therein, the conditions are different. The delivery surface formed during the manufacture of the reservoir is maintained in its entire size over the entire administration period. The active substance passing through it leaves behind in the reservoir a zone parallel to the delivery surface with a reduced active substance concentration compared with the remainder of the reservoir and whose further dilution is avoided by a subsequent supply of active substance from the more highly concentrated reservoir part. Thus, the quantity delivered through the delivery surface is defined by the extent of the subsequently supplied active substance, so that the thickness of the zone constantly increases with reduced concentration. Thus, parallel to the delivery surface is formed a type of separating surface between the reservoir parts with reduced concentration and increased original concentration, whose spacing with respect to the delivery surface constantly rises during administration and whose size corresponds to the reservoir cross-section parallel to the delivery surface. The size of this separating surface and therefore the cross-section of the reservoir consequently determines the delivery rate of active substance through the delivery surface. According to the invention the size of the separating surface is defined by a corresponding geometrical configuration of the reservoir and is reduced in planned manner, so that the delivery quantity of active substance from the reservoir is reduceable in a clearly defined and controlled manner compared with the initial quantity.
The cross-sectional reduction can also be continuously adjusted over the entire reservoir and there can be a difference in a linear or non-linear pattern of the reduction. If necessary, it is also possible to achieve a discontinuous, e.g. step-like cross-sectional reduction. Here again, the pattern can be linear or non-linear.
Appropriate geometrical shapes for the reservoir are e.g. cones, truncated cones, pyramids, truncated pyramids, tetrahedrons, truncated tetrahedrons, hemispheres, spherical segments and spherical layers. The reservoir can natur
Ghali Isis
Gilster Peter S.
LTS Lohmann Therapie-Systeme GmbH & Co. KG
Page Thorman K.
LandOfFree
Reservoir for controlled active substance delivery, and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Reservoir for controlled active substance delivery, and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Reservoir for controlled active substance delivery, and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2543486